Global animal health leader adopts Veeva Vault Clinical and Veeva Vault RIM for greater efficiency, visibility, and speed PLEASANTON, Calif., Feb. 14, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Boehringer Ingelheim has selected Veeva Vault Clinical and Veeva Vault RIM applications as its technology foundation for clinical and regulatory management in its animal health business unit. By adopting unified applications on a single platform, Boehringer Ingelheim can streamline clinical ...

Veeva Systems新产品发布 - Veeva Systems宣布推出Veeva Vault Submissions Publishing eLearning，这是一款新的监管信息管理(RIM)应用程序，旨在教育用户关键的发布流程，以便顺利开发符合规定的内容[1] - Vault Submissions Publishing eLearning为员工提供资源，使其保持合格和了解最新功能和技术，以实现高效的持续发布[2] - Veeva的Vault Submissions Publishing eLearning计划于2024年3月推出，更多信息可在2月12-14日在马里兰州举办的DIA RSIDM论坛212号展位了解[5]

股价表现 - Veeva Systems 最近的股价为 $204.24，较前一交易日收盘价下跌了 -1.24% [1] - Veeva Systems 过去一个月的股价上涨了 11.37%，超过了计算机和技术行业的涨幅 9.33% 和标普500指数的涨幅 4.59% [2] 财务预测 - Veeva Systems 预计每股收益为 $1.30，同比增长 13.04%，预计营收为 $620.75 亿美元，同比增长 10.18% [3] 分析评级 - Veeva Systems 目前的 Zacks Rank 为 2 (买入)，过去30天内，公司的一致EPS预测上调了 0.53% [6] 估值比较 - Veeva Systems 目前的前瞻市盈率为 37.3，高于行业平均值 31.21 [7] - Veeva Systems 目前的PEG比率为 1.51，略低于互联网-软件行业的平均值 1.68 [8] 行业排名 - 互联网-软件行业属于计算机和技术行业，该行业的 Zacks Industry Rank 为 80，在所有250+个行业中排名前32% [9] 信息来源 - 利用 Zacks.com 可以关注所有这些影响股价的指标，在未来的交易中 [11]

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Veeva Systems (VEEV) , which belongs to the Zacks Internet - Software industry. When looking at the last two reports, this provider of cloud-based software services for the life sciences industry has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 6.36%, on average, in the last two quarters. For the last reported ...

Veeva Systems (VEEV) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, VEEV crossed above the 20-day moving average, suggesting a short-term bullish trend. The 20-day simple moving average is a well-liked trading tool because it provides a look back at a stock's price over a 20-day period. Additionally, short-term traders find this SMA very beneficial, as it smooths out short- term price trends and shows more trend reversal signals tha ...

Complete suite of modern patient, prescriber, and national data products for today's complex therapies Compass Prescriber includes HCP-level projections for more than 4,000 brands and their prescriptions and procedures PLEASANTON, Calif., Jan. 30, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced the availability of the full Veeva Compass Suite of commercial data products for a more complete view into patient populations and HCP-level insight. Veeva Compass Prescriber and Veeva Compass Nationa ...

SOPA Images/LightRocket via Getty Images Investment Thesis Veeva Systems Inc. (NYSE:VEEV) has been a very volatile stock in the past 12 months. The stock is far from blemish-free. For one, there are significant questions over its sustainable go-forward revenue growth rates. On top of that, the previous 3 quarters have seen Veeva's non-GAAP operating margins compress. Despite these considerations, I declare that investors will in the next 12 months look back to $175 per share as an attractive entry point (bu ...

Hiraman Summary I am recommending a buy rating for Veeva Systems (NYSE:VEEV). I think the business is well positioned to consolidate market share in an industry that is ripe for technology upgrades. The nature of VEEV solutions also means that they are very sticky and this enables VEEV to easily cross-sell other products to further anchor itself into the customer's workflow processes. As growth and margin recover, I expect the market to re-rate VEEV back to its normalized multiple of 37x forward EBITDA. Bus ...

Veeva Systems (VEEV) closed at $209.38 in the latest trading session, marking a +1.08% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.22% for the day. Elsewhere, the Dow gained 0.36%, while the tech-heavy Nasdaq added 0.32%. The provider of cloud-based software services for the life sciences industry's shares have seen an increase of 8.54% over the last month, surpassing the Computer and Technology sector's gain of 3.64% and the S&P 500's gain of 1.61%. Market particip ...

Complete life sciences GxP training solution delivers audit readiness PLEASANTON, Calif., Jan. 18, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 350 companies are using Veeva training solutions to modernize employee qualification processes. A growing number of biopharmas are adopting end-to-end learning management for advanced employee education and compliance. "Veeva is helping us streamline GxP training to speed employee qualification and onboarding as we grow," said Debra ...